IPHA
Price
$1.80
Change
-$0.12 (-6.25%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
182.14M
Earnings call today
Intraday BUY SELL Signals
VALN
Price
$9.13
Change
-$0.06 (-0.65%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
762.94M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

IPHA vs VALN

Header iconIPHA vs VALN Comparison
Open Charts IPHA vs VALNBanner chart's image
Innate Pharma SA
Price$1.80
Change-$0.12 (-6.25%)
Volume$1.11K
Capitalization182.14M
Valneva SE
Price$9.13
Change-$0.06 (-0.65%)
Volume$200
Capitalization762.94M
IPHA vs VALN Comparison Chart in %
IPHA
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IPHA vs. VALN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Hold and VALN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (IPHA: $1.92 vs. VALN: $9.19)
Brand notoriety: IPHA and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 33% vs. VALN: 12%
Market capitalization -- IPHA: $182.14M vs. VALN: $762.94M
IPHA [@Biotechnology] is valued at $182.14M. VALN’s [@Biotechnology] market capitalization is $762.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 4 TA indicator(s) are bullish while VALN’s TA Score has 4 bullish TA indicator(s).

  • IPHA’s TA Score: 4 bullish, 7 bearish.
  • VALN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VALN is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а +5.49% price change this week, while VALN (@Biotechnology) price change was +2.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

IPHA is expected to report earnings on Nov 13, 2025.

VALN is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($763M) has a higher market cap than IPHA($182M). VALN YTD gains are higher at: 110.201 vs. IPHA (4.348).
IPHAVALNIPHA / VALN
Capitalization182M763M24%
EBITDAN/A-20.38M-
Gain YTD4.348110.2014%
P/E RatioN/AN/A-
RevenueN/A196M-
Total CashN/A161M-
Total DebtN/A197M-
FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAVALN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
73%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signal:
Gain/Loss:
VALN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DIGTF0.02N/A
N/A
Thruvision Group PLC
HNSPF5.00N/A
N/A
Hansoh Pharmaceutical Group Co Ltd.
SLFPF2.57N/A
N/A
ABERDEEN GROUP PLC
WTBFA585.00N/A
N/A
W.T.B. Financial Corp.
MTWO0.10N/A
-1.00%
M2i Global, Inc.

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-10.28%
MDGL - IPHA
43%
Loosely correlated
-2.32%
APLM - IPHA
36%
Loosely correlated
+7.90%
SLNO - IPHA
34%
Loosely correlated
-1.99%
VALN - IPHA
30%
Poorly correlated
+3.37%
TNXP - IPHA
30%
Poorly correlated
+1.08%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+3.37%
INRLF - VALN
42%
Loosely correlated
+0.05%
ORKA - VALN
35%
Loosely correlated
+0.35%
PTCT - VALN
32%
Poorly correlated
+1.53%
IPHA - VALN
32%
Poorly correlated
-10.28%
ZNTL - VALN
30%
Poorly correlated
-4.29%
More